Allogeneic marrow transplantation in patients with severe systemic sclerosis: Resolution of dermal fibrosis
Richard A. Nash(Colorado Blood Cancer Institute), Daniel E. Furst(University of California, Los Angeles), Gretchen Henstorf(Fred Hutch Cancer Center), Amelia Langston(CancerCare Manitoba), Mark H. Wener(University of Washington), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Julie Lee(Aneurin Bevan University Health Board), Peter A. McSweeney(Mesoblast (United States)), Howard M. Shulman(Fred Hutch Cancer Center), George E. Georges(Northwestern University), J. Lee Nelson(University of Washington), Keith M. Sullivan(Duke Medical Center)
Cited by 76
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis & Rheumatology|2015|2.8k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k